NDC 42291-474

etravirine

etravirine is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Avkare. The primary component is Etravirine.

Product ID	42291-474_ea385c97-88db-05f4-e053-2a95a90aecee
NDC	42291-474
Product Type	Human Prescription Drug
Proprietary Name	etravirine
Generic Name	Etravirine
Dosage Form	Tablet
Route of Administration	ORAL
Marketing Start Date	2022-10-04
Marketing Category	ANDA /
Application Number	ANDA214196
Labeler Name	AvKARE
Substance Name	ETRAVIRINE
Active Ingredient Strength	200 mg/1
Pharm Classes	Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
NDC Exclude Flag	N
Listing Certified Through	2023-12-31